¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Other pulmonary valve disorders"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • pulmonary infarction
    Æó°æ»öÁõ, ÇãÆÄ°æ»öÁõ
  • pulmonary insufficiency
    Æó±â´ÉºÎÀü, ÇãÆÄ±â´ÉºÎÀü
  • pulmonary juxtaesophageal lymph node
    ÇãÆÄ½Äµµ¿·¸²ÇÁÀý, Æó½Äµµ¿·¸²ÇÁÀý
  • pulmonary mucormycosis
    ÆóÅаõÆÎÀÌÁõ, ÇãÆÄÅаõÆÎÀÌÁõ
  • pulmonary oligemia
    ÆóÇ÷¾×·®°¨¼Ò
  • pulmonary overinflation syndrome
    Æó°úµµÆØÃ¢ÁõÈıº
  • pulmonary perfusion scan
    Æó°ü·ù½ºÄµ, ÇãÆÄ°ü·ù½ºÄµ
  • pulmonary plethora
    Æó´ÙÇ÷Áõ
  • pulmonary pulse
    Æóµ¿¸Æ¹Ú
  • pulmonary sarcoidosis
    Æó»ç¸£ÄÚÀ̵åÁõ
  • pulmonary schistosomiasis
    ÆóÁÖÇ÷ÈíÃæÁõ
  • pulmonary scintigraphy
    Æó¼¶±¤Á¶¿µ(¼ú), ÇãÆÄ¼¶±¤Á¶¿µ(¼ú)
  • pulmonary sequestration
    ÆóºÐ¸®Áõ, ÇãÆÄºÐ¸®Áõ
  • pulmonary stenosis
    Æóµ¿¸ÆÆÇÇùÂø(Áõ)
  • pulmonary strongyloidiasis
    ÆóºÐ¼±ÃæÁõ, ÇãÆÄºÐ¼±ÃæÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • pulmonary hypertension
    Æóµ¿¸Æ°íÇ÷¾Ð, ÇãÆÄ°íÇ÷¾Ð
  • intralobar pulmonary sequestration
    ¿±³»ÇãÆÄºÐ¸®Áõ
  • pulmonary infarction
    Æó°æ»öÁõ, ÇãÆÄ°æ»öÁõ
  • pulmonary juxtaesophageal node lymph
    ÇãÆÄ½Äµµ¿·¸²ÇÁÀý, Æó½Äµµ¿·¸²ÇÁÀý
  • pulmonary mucormycosis
    ÇãÆÄÅаõÆÎÀÌÁõ, ÆóÅаõÆÎÀÌÁõ
  • pulmonary mycobacteriosis
    ÇãÆÄ¹ÌÄÚ¹ÚÅ×·ýÁõ, Æó¹ÌÄÚ¹ÚÅ×·ýÁõ
  • pulmonary hyaline membrane
    ÇãÆÄÀ¯¸®Áú¸·, ÆóÀ¯¸®Áú¸·
  • pulmonary oligemia
    ÆóÇ÷·®°¨¼Ò
  • pulmonary
    ÇãÆÄ-, Æó-
  • pulmonary plethora
    ÆóÇ÷·®Áõ°¡
  • pulmonary pulse
    Æóµ¿¸Æ¹Ú
  • pulmonary sarcoidosis
    ÇãÆÄ»ç¸£ÄÚÀ̵åÁõ, Æó»ç¸£ÄÚÀ̵åÁõ
  • pulmonary schistosomiasis
    ÇãÆÄÁÖÇ÷ÈíÃæÁõ, ÆóÁÖÇ÷ÈíÃæÁõ
  • pulmonary scintigraphy
    ÇãÆÄ½ÅƼ±×·¡ÇÇ, Æó½ÅƼ±×·¡ÇÇ
  • pulmonary sequestration
    ÇãÆÄºÐ¸®Áõ, ÆóºÐ¸®Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • anomalous pulmonary venous drainage
    ÆóÁ¤¸ÆÈ¯·ù(̰?ËÎÌ·Ëô)ÀÌ»ó.
  • anomalous pulmonary venous return
    ÆóÁ¤¸ÆÈ¯·ùÀÌ»ó.
  • gravistatic pulmonary congestion
    Á߷¼º Æó ¿ïÇ÷.
  • high altitude pulmonary edema
    °íÁöÆóºÎÁ¾.
  • hypertrophic pulmonary osteoarthropathy
    ºñÈļº<ºñ´ë¼º> Æó °ñ°üÀýº´Áõ.
  • hypertrophic pulmonary osteoarthropathy
    ºñÈļº<ºñ´ë¼º>Æó°ñ°üÀýº´Áõ.
  • hypoxic pulmonary vasoconstriction
    Àú»ê¼Ò¼º ÆóÇ÷°ü¼öÃà(î¸ß«áÈàõ øËúìηâ¥õê).
  • hypoxic pulmonary vasoconstriction
    Àú»ê¼Ò¼º ÆóÇ÷°ü¼öÃà.
  • idiopathic pulmonary fibrosis
    Ư¹ß¼º Æó¼¶À¯È­Áõ(¡­øËàéë«ûùñø)
  • idiopathic pulmonary hemosiderosis
    Ư¹ß¼º ÆóÇ÷öÁõ(¡­øËúìôÑñø).
  • idiopathic pulmonary hemosiderosis
    Ư¹ß¼º ÆóÇ÷öÁõ
  • plexogenic pulmonary arteriopathy
    ÃÑÇü¼º Æóµ¿¸Æº´Áõ(õ¿û¡àõ øËÔÑØæÜ»ñø)
  • posterior pulmonary lymph nodes
    µÚÆó¸²ÇÁÀý, ÈÄÆó(ý­øË)¸²ÇÁÀý.
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(¡­øËÍÔúìäâñø).
  • primary pulmonary hypertension
    ¿ø¹ß(¼º) Æó°íÇ÷¾ÐÁõ(ê«Û¡(àõ) øËÍÔúìäâñø)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • steroid-related disorders
    ½ºÅ×·ÎÀÌµå °ü·ÃÀå¾Ö(º´).
  • stress-related disorders
    ½ºÆ®·¹½º °ü·ÃÀå¾Ö(º´).
  • sweating disorders
    ¹ßÇÑÀå¾Ö(Û¡ùÒî¡äô)
  • temperature-dependent skin disorders
    ¿ÂµµÀÇÁ¸ ÇǺκ´
  • tobacco-related disorders
    Åä¹ÙÄÚ(´ã¹è)°ü·ÃÀå¾Ö(~º´).
  • topographic localization disorders
  • voice disorders, organic
    ±âÁú(Àû) À½¼ºÀå¾Ö
  • voice disorders, psychogenic
    ½ÉÀÎ(¼º) À½¼ºÀå¾Ö
  • x linked disorders
    X¿¬°ü(XÀÇÁ¸)Àå¾Ö, X¿¬°üÁúº´
  • adjustable pressure limiting valve
    Á¶ÀýÇü ¾Ð·ÂÁ¦ÇÑ ¹ëºê.
  • anterior semilunar valve
    ¾Õ¹Ý´ÞÆÇ¸·
  • antirflux valve
    Ç׿ª·ù ÆÇ¸·
  • aortic valve
    ´ëµ¿¸ÆÆÇ¸·
  • aortic valve prosthesis
    Àΰø´ëµ¿¸ÆÆÇ.
  • aortic valve,bicuspid calcification
    ÀÌÆÇ ¼®È¸È­(ì£÷ûà´üéûù)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
AODP alcohol and other drug problems
beta [Greek letter beta] an anomer of a carbohydrate; buffer capacity; carbon separated from a carboxyl by one other carbon i...
DO Doctor of Osteopathy (one of two fully recognized medical practioners in the US-the other being MD);...
DRO differential reinforcement of other behavior; Disablement Resettlement Officer
EOD entry on duty; every other day
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SVD Structural Valve Deterioration
TVR Tricuspid valve replacement
DVR and mitral valve replacement
AV aortic valve
AS aortic valve stenosis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pulmonary atelectasis
    ¹«±âÆó
  • pulmonary atresia
    Æóµ¿¸ÆÆÇ Æó¼â, Æóµ¿¸ÆÆÇ Æó¼âÁõ
    ¿ì½É½Ç¿¡¼­ ±â½ÃÇÏ´Â Æó µ¿¸ÆÀÌ ¿ÏÀüÈ÷ ´ÜÀýµÇ¾î Ç÷·ù°¡ ³ª°¥ ¼ö ¾ø´Â »óŸ¦ ¸»ÇÑ´Ù. ½É½Ç Áß°Ý °á¼ÕÁõÀÌ ÀÖÀ» ¼öµµ ÀÖ°í ¾øÀ» ¼öµµ Àִµ¥ ½É½Ç Áß°Ý °á¼ÕÁõÀÌ ¾øÀ» °æ¿ì´Â ¿ì½É½Ç¿¡ Ç÷·ùÀÇ ºÎÇϰ¡ ³Ê¹« ¸¹ÀÌ °É·Á ž Á÷ÈĺÎÅÍ º¹ÀâÇÑ º´¸®¸¦ ³ªÅ¸³»¸ç ½ÉÇÑ Áõ¼¼¸¦ º¸ÀδÙ. À̶§´Â ¶ÇÇÑ ½É¹æ Áß°Ý °á¼ÕÁõÀÌ ÀÖ¾î¾ß »ýÁ¸ÇÒ ¼ö ÀÖ´Ù. ½É½Ç Áß°Ý °á¼ÕÀÌ ¾ø´Â Æóµ¿¸ÆÀÇ Æó¼â´Â ¿ì½É½ÇÀÇ ºñ´ë´Â ¹°·Ð ¿ì½É½Ç¿¡¼­ °ü»ó µ¿¸ÆÀ¸·Î Ç÷·ù°¡ È帣´Â µî º¹ÀâÇÑ º´¸®°¡ ÀÖ´Ù. ±×¸®°í Æóµ¿¸Æ Æó¼â·Î ÀÎÇØ Æóµ¿¸ÆÀ¸·Î °¡´Â Ç÷·ù´Â ´ëµ¿¸Æ¿¡¼­ ±â½ÃÇØ¾ß Çϴµ¥ ÀÌ ¶ÇÇÑ ¸Å¿ì º¹ÀâÇÑ °æ·Î¸¦ ÅëÇØ ¿¬°áµÈ´Ù. ´Ü¼øÈ÷ Æóµ¿¸ÆÆÇ¸·¸¸ Æó¼âµÇ¾úÀ» °æ¿ì¿¡´Â µ¿¸Æ°ü °³Á¸ÁõÀ» ÅëÇØ Ç÷·ù°¡ À¯ÁöµÇ´Â °æ¿ì°¡ ¸¹Áö¸¸ ±×·¸Áö ¾Ê´Â °æ¿ì ´ëµ¿¸ÆÀÇ ¿©·¯ ±ºµ¥¿¡¼­ °¢°¢ µû·Îµû·Î Ç÷·ù°¡ ³ª¿Í ¼ö¼úÀ» ¸Å¿ì ¾î·Æ°Ô ¸¸µé ¼öµµ ÀÖ´Ù. ¼±Ãµ¼º û»öÁõÇü ½ÉÀ庴 Áß¿¡¼­µµ ¾î·Á¿î ¼ö¼ú ÁßÀÇ ÇϳªÀÌ´Ù. º´º¯ÀÌ º¹ÀâÇØ¼­ ÀÏ¹Ý ½ÉÀå ¼ö¼ú·Î ±³Á¤ÀÌ ºÒ°¡´ÉÇÒ ¶§´Â ½ÉÀå Æó µ¿½Ã À̽ÄÀ» ÇØÁÖ¾î¾ß ÇÑ´Ù.
  • pulmonary capillary wedge pressure
    Æó¸ð¼¼Ç÷°ü ½û±â¾Ð
  • pulmonary collapse
    Æó ÇãÅ»
  • pulmonary cyanosis
    Æó¼º û»öÁõ
    Æó Ç÷¾×ÀÇ »ê¼Ò Æ÷È­ °áÇÌ¿¡ ÀÇÇÑ ÁßÃß¼º û»öÁõ.
  • pulmonary edema
    Æó ºÎÁ¾, Æó ¼öÁ¾
    ÆóÆ÷¿Í ¼¼±â°üÁö ³»¿¡ ¾×ü°¡ Âù »óÅÂ.
  • pulmonary emphysema
    Æó ±âÁ¾
    ÆóÆ÷°¡ ÇöÀúÇÏ°Ô È®ÀåÇÏ¿© ÆóÆ÷ ³»ÀÇ ÇԱⷮÀÌ Áõ°¡ÇÑ »óÅÂ. ¿©·¯ °¡Áö ¿øÀÎÀ¸·Î ÀϾÁö¸¸, °¡Àå º¸ÆíÀûÀ¸·Î º¼ ¼ö ÀÖ´Â °ÍÀº ³ëÀμº Æó±âÁ¾ÀÌ´Ù. ±× ¹Û¿¡ ±â°üÁö õ½Ä, ¸¸¼º ±â°üÁö¿° µîÀ¸·Î ÀϾ´Ù. Á÷¾÷º´À¸·Î¼­´Â ÃëÁ־DZâÀÇ ¿¬ÁÖÀÚ µî¿¡¼­µµ º¼ ¼ö ÀÖ´Ù. È£Èí °ï¶õ, ±âħ µîÀÇ Áõ¼¼¸¦ ³ªÅ¸³»¸ç, õ½Ä°ú ºñ½ÁÇÑ È£Èí °ï¶õµµ º¸ÀδÙ. ÁßÁõÀÎ °æ¿ì´Â ½ÉÀå¿¡ ºÎ´ãÀ» ÁÖ¾î Æó¼º ½ÉÀ¸·Î ÁøÇàÇÏ¿© ºÎÁ¾, Ä¡¾Æ³ëÁ¦°¡ ³ªÅ¸³­´Ù. ÈäºÎ X¼± »çÁø¿¡¼­´Â Æó¾ß°¡ ¹à°Ô ³ªÅ¸³ª°í, Ⱦ°Ý¸·ÀÌ Á¤»óº¸´Ù ³·Àº À§Ä¡¿¡ ÀÖ´Ù. Ä¡·á·Î¼­´Â ±â°üÁö È®ÀåÁ¦, ºÎ½Å ÇÇÁú È£¸£¸óÀÇ Åõ¿©°¡ À¯È¿ÇÏ´Ù. ÁßÁõÀÎ °æ¿ì´Â °­½ÉÁ¦¿Í ÀÌ´¢Á¦ÀÇ Åõ¿©³ª »ê¼Ò ÈíÀÔÀ» ÇÊ¿ä·Î ÇÑ´Ù.
  • pulmonary failure
    Æó ºÎÀü
  • pulmonary function
    Æó ±â´É
  • pulmonary hamartoma
    Æó °ú¿ÀÁ¾
  • pulmonary hemorrhage
    Æó ÃâÇ÷
  • pulmonary hypertension
    Æó ¼øÈ¯ ½Â¾Ð, Æó °íÇ÷¾ÐÁõ
  • pulmonary infarct
    Æó °æ»ö
  • pulmonary infection
    Æó °¨¿°
  • pulmonary insufficiency
    Æó µ¿¸ÆÆÇ¸· Æó¼â ºÎÀü, Æó µ¿¸ÆÆÇ¸· Æó¼â ºÎÀüÁõ, Æó ±â´É ºÎÀü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
sexual and gender disorders Mental disorders related to sexual dysfunction, paraphillias, and gender identity disorders.
(12 Dec 1998)
sleep disorders Disturbances of usual sleep patterns or behaviours.
(12 Dec 1998)
social behaviour disorders Behaviours which are at variance with the expected social norm and which affect other individuals.
(12 Dec 1998)
somatoform disorders Disorders having the presence of physical symptoms that suggest a general medical condition and that are not fully explained by a general medical condition, by the direct effects of a substance, or by another mental disorder. The symptoms must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to factitious disorders and malingering, the physical symptoms are not under voluntary control.
(12 Dec 1998)
speech disorders Long-term disorders in speaking or in perception of speech.
(12 Dec 1998)
necrobiotic disorders A group of disorders characterised by swelling, basophilia, and distortion of collagen bundles in the dermis.
(12 Dec 1998)
neurotic disorders Disorders in which the symptoms are distressing to the individual and recognised by him or her as being unacceptable. Social relationships may be greatly affected but usually remain within acceptable limits. The disturbance is relatively enduring or recurrent without treatment.
(12 Dec 1998)
stress disorders, posttraumatic Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event and numbing of responsiveness to or reduced involvement with the external world.
(12 Dec 1998)
substance abuse disorders A class of mental disorders in which behavioural and biological changes are associated with regular use of alcohol, drugs, and related substances that affect the central nervous system and personal and social functioning.
(05 Mar 2000)
substance-induced organic mental disorders Mental disorders caused by use of drugs, e.g., cocaine.
(05 Mar 2000)
substance-related disorders These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure.
(12 Dec 1998)
delirium, dementia, amnestic, cognitive disorders Cognitive disorders including delirium, dementia, and other cognitive disorders. These may be the result of substance use, trauma, or other causes.
(12 Dec 1998)
disorders, myeloproliferative Tumours of certain bone marrow cells including those that give rise to red cells, granulocytes, and platelets. As opposed to the lymphoproliferative disorders.
(12 Dec 1998)
dissociative disorders Sudden temporary alterations in the normally integrative functions of consciousness.
(12 Dec 1998)
immunodeficiency disorders <radiology> B-cell (antibody) deficiency: high-grade pathogens: pneumococcus, strep, H. Flu, chronic sinopulmonary disease, usual survival to adulthood, T-cell (cellular) deficiency: low-grade pathogens: fungi, viruses, Pneumocystic, growth retardation, diarrhoea, delayed anergy, short life-span, susceptible to graft vs. Host (GvH) disease, e.g.: DiGeorge syndrome, Nezelhof syndrome Note: increased risk of malignancy
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á